Scarica l'app Stockscreener
1.92
2.54%
-0.05
Dopo l'orario di chiusura:
1.85
-0.07
-3.65%
MAIA Biotechnology Inc Borsa (MAIA) Ultime notizie
Why MAIA Biotechnology Inc. stock could benefit from AI revolution2025 Trading Volume Trends & Stepwise Trade Execution Plans - mfd.ru
Does MAIA Biotechnology Inc. have pricing power2025 Performance Recap & Low Risk High Win Rate Picks - mfd.ru
What’s the MACD signal for MAIA Biotechnology Inc.2025 Macro Impact & Low Risk High Win Rate Stock Picks - mfd.ru
Is MAIA Biotechnology Inc. showing insider buying2025 EndofYear Setup & Weekly High Return Forecasts - mfd.ru
What are the future prospects of MAIA Biotechnology IncSwing Trade & Daily Technical Forecast Reports - baoquankhu1.vn
MAIA Biotechnology (NYSEAMERICAN:MAIA) Shares Up 0.5% – Should You Buy? - Defense World
MAIA Biotechnology (NYSEAMERICAN:MAIA) Shares Up 0.5%Should You Buy? - MarketBeat
Fed Watch: Will MAIA Biotechnology Inc outperform small cap indexes2025 Market Sentiment & Safe Investment Capital Preservation Plans - baoquankhu1.vn
MAIA Biotechnology announces significant insider buying - MSN
Risk Analysis: Is Roblox Corporation stock risky to hold now2025 Year in Review & High Accuracy Investment Signals - baoquankhu1.vn
$207B Market Shift: The Race for Fast Track Approval in Oncology (2026-02-05) - Seeking Alpha
$207B Market Shift: The Race for Fast Track Approval in Oncology - Sahm
Geopolitics Watch: What are the future prospects of MAIA Biotechnology IncTrade Analysis Summary & Reliable Volume Spike Trade Alerts - baoquankhu1.vn
Late-Stage Breakthroughs: How 2026's Top Clinical Platforms Are Redefining Cancer Treatment - The Globe and Mail
Late-Stage Breakthroughs: How 2026’s Top Clinical Platforms Are Redefining Cancer Treatment - Cantech Letter
Growth Value: Is MAIA Biotechnology Inc stock forming a cup and handleJuly 2025 Gainers & Long Hold Capital Preservation Plans - baoquankhu1.vn
Aug Highlights: What is MAIA Biotechnology Incs TAM Total Addressable Market2025 Institutional Moves & Stock Timing and Entry Methods - baoquankhu1.vn
Buyback Watch: Is Milestone Pharmaceuticals Inc undervalued by DCF analysis2025 Volume Leaders & Fast Momentum Stock Entry Tips - baoquankhu1.vn
Tech Rally: What are the future prospects of MAIA Biotechnology Inc2025 Growth vs Value & Accurate Buy Signal Notifications - baoquankhu1.vn
MAIA 's Outlines 2026 Milestones On Ateganosine In Cancer Treatment Program; Stock Down - Nasdaq
MAIA Biotechnology outlines 2026 goals for ateganosine program - TipRanks
MAIA Biotechnology Advances Ateganosine Cancer Treatment Program - TradingView — Track All Markets
MAIA Biotechnology Advances Ateganosine Cancer Treatment Program, Outlines Targeted 2026 Clinical Milestones and Growth Momentum - The Manila Times
MAIA Biotechnology Advances Ateganosine Cancer Treatment - GlobeNewswire
MAIA Targets 2026: Strong Clinical Data for Ateganosine - Intellectia AI
MAIA Biotechnology (NYSEAMERICAN:MAIA) Shares Up 9.4% – Time to Buy? - Defense World
MAIA Biotechnology (NYSEAMERICAN:MAIA) Shares Up 9.4%Time to Buy? - MarketBeat
Trend Report: Should I buy BOSC stock nowJuly 2025 Highlights & AI Powered Trade Plan Recommendations - baoquankhu1.vn
MAIA Biotechnology (MAIA) Price Target Decreased by 15.37% to 10.48 - Nasdaq
MAIA Biotechnology Highlights Strategy in New Investor Presentation - TipRanks
Smith Stan buys MAIA Biotechnology shares worth $9,958 By Investing.com - Investing.com Australia
Smith Stan buys MAIA Biotechnology shares worth $9,958 - Investing.com
Will MAIA Biotechnology Inc. stock sustain dividend payoutsJuly 2025 Opening Moves & Risk Managed Investment Strategies - Улправда
Will MAIA Biotechnology Inc. stock deliver compounding returns2025 Fundamental Recap & AI Forecasted Entry and Exit Points - Улправда
Can MAIA Biotechnology Inc. stock deliver strong annual returnsWeekly Trade Recap & Expert Curated Trade Ideas - Улправда
MAIA Biotechnology (MAIA) director granted 24,060 options under 2021 plan - Stock Titan
MAIA Biotechnology (MAIA) director reports grant of 29,216 stock options - Stock Titan
MAIA Biotechnology (MAIA) director receives 25,206 stock options exercisable at $1.53 - Stock Titan
MAIA Biotechnology, Inc. (MAIA) reports 29,789 director stock options at $1.53 - Stock Titan
[Form 4] MAIA Biotechnology, Inc. Insider Trading Activity - Stock Titan
MAIA Biotechnology (NASDAQ: MAIA) reports 24,633 stock options grant - Stock Titan
A stock that deserves closer examination: MAIA Biotechnology Inc (MAIA) - uspostnews.com
MAIA Biotechnology, Inc. Common Stock (NYSE:MAIA) Stock Quote - FinancialContent
MAIA Biotechnology announces open market purchases by CEO, directors - MSN
MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) Short Interest Up 144.9% in December - MarketBeat
MAIA Biotechnology (MAIA) Price Target Decreased by 13.32% to 12.38 - MSN
MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings - The Manila Times
Louie Ngar Yee buys MAIA Biotechnology (MAIA) shares worth $99999 By Investing.com - Investing.com Canada
Stan Smith buys MAIA Biotechnology shares worth $69,999 By Investing.com - Investing.com Canada
Chaouki Steven M buys MAIA Biotechnology shares worth $49999 By Investing.com - Investing.com Australia
Stan Smith buys MAIA Biotechnology shares worth $69,999 - Investing.com
Louie Ngar Yee buys MAIA Biotechnology (MAIA) shares worth $99999 - Investing.com
1.12%
0.87%
Capitalizzazione:
|
Volume (24 ore):